Latest Posts
About This Stock
More About This Stock
Read
Read
ETFs To Buy As Eli Lilly Beats Q1 Earnings, Lifts Outlook
Article By:
Sweta Killa
Wednesday, May 1, 2024 1:55 PM EDT
Eli Lilly and Company posted mixed first-quarter 2024 earnings, beating earnings estimates but lagging on revenues. Investors seeking to tap the opportune moment could bet on ETFs having the largest exposure to the drugmaker.
Government-Granted Patent Monopolies Are Not The Free Market
Article By:
Dean Baker
Friday, December 29, 2023 10:45 PM EDT
The American system generally sees monopolies as antithetical to free markets. The patent monopolies that government grants to pharmaceutical companies demonstrate why it's such a bad idea.